Sort
11,323 grants matching “glioblastoma”
A multimodal single-cell approach to developing personalized combinatorial treatments for glioblastoma
$156,145Allegra Adele Petti · Massachusetts General Hospital · R21 · FY2025 · CA
DEVELOPMENT OF NOVEL THERAPY FOR GLIOBLASTOMA TARGETING THERAPY-RESISTANT CELL POPULATION BY MODULATION OF DNA REPAIR
$156,000Regents Of The University Of Michigan · · FY2022 · Defense Health Agency
Simultaneous targeting of tumor cells and tumor associated macrophages by RNA nanovector
$156,000Tae Jin Lee · University Of Texas Hlth Sci Ctr Houston · R03 · FY2021 · CA
Whole transcriptome analysis for neurobiology
$155,953Alex Ryutov · Epicenter Software · R44 · FY2012 · NS
SU 101 VERSUS PROCARBAZINE FOR PATIENTS W/ GLIOBLASTOMA
$155,764University Of Southern California · M01 · FY2001 · RR
Chemical Engineering of Extracellular Vesicles for Enhanced Glioblastoma Therapy: Undergraduate Biomedical Research at Southern Utah University
$155,695Jessica Pullan · Utah State Higher Education System--Southern Utah University · R16 · FY2025 · GM
Pathology Core
$155,602Keith L Ligon · Massachusetts General Hospital · P50 · FY2014 · CA
Pre-Clinical Vector Production Core
$155,559William F. Goins · Brigham And Women'S Hospital · P01 · FY2021 · CA
microRNA therapies for advanced brain tumors
$155,412Deepak Bhere · Brigham And Women'S Hospital · K99 · FY2020 · CA
An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM
$155,233Jianhua Yu · Beckman Research Institute/City Of Hope · U19 · FY2023 · CA
MDM2 inhibitor therapy for TP53 wild-type GBM
$155,170Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2022 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2022 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2020 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2021 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2019 · CA
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
$155,127Melissa Ann Fath · University Of Iowa · R50 · FY2023 · CA
Therapy Evaluation Core
$155,094Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2022 · CA
Proteomics Shared Resource
$155,039Daniel Jon McCormick · Mayo Clinic Rochester · P30 · FY2019 · CA
In vivo relevance of the Schlafen-mediated innate immune mechanism in flavivirus infection
$154,712Manuel Llano · University Of Texas El Paso · R16 · FY2025 · AI
In vivo relevance of the Schlafen-mediated innate immune mechanism in flavivirus infection
$154,648Manuel Llano · University Of Texas El Paso · R16 · FY2024 · AI
P I/II Intraventricular DepoCyt (OD # 06-2348) in Glioblastoma (76,730, 11/06)
$154,552Bruce Michael Frankel · Medical University Of South Carolina · R01 · FY2010 · FD
Mitochondrial Dysfunction and Chemoresistance in Malignant Gliomas
$154,539Corinne E. Griguer · University Of Alabama At Birmingham · R21 · FY2011 · CA
Magnetic Particle Imaging (MPI) for Imaging and Magnetothermal Therapy of Brain Tumors
$154,529Hamed Arami · Stanford University · K99 · FY2020 · CA
Magnetic Particle Imaging (MPI) for Imaging and Magnetothermal Therapy of Brain Tumors
$154,529Hamed Arami · Stanford University · K99 · FY2021 · CA
Role of aging-dependent changes in neuronal sub-types in development of radiotherapy-induced cognitive decline in the elderly population
$154,500Bogdan Adrian Stoica · University Of Maryland Baltimore · R03 · FY2022 · AG